Cargando…
Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity
Oncolytic peptides are highly effective on remodeling the tumor microenvironment and potentiating the anticancer immunity through multiple mechanisms, particularly by inducing immunogenic cell death. Intriguingly, a recent study demonstrates that LTX-315, one of the most promising and extensively st...
Autores principales: | Tang, Tianyu, Huang, Xing, Zhang, Gang, Liang, Tingbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295653/ https://www.ncbi.nlm.nih.gov/pubmed/35851309 http://dx.doi.org/10.1136/jitc-2022-005065 |
Ejemplares similares
-
Two roads for oncolytic immunotherapy development
por: Kaufman, Howard L., et al.
Publicado: (2019) -
Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis
por: Tang, Tianyu, et al.
Publicado: (2022) -
Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
por: Zhao, Yaqi, et al.
Publicado: (2021) -
Oncolytic immunotherapy for metastatic cancer: lessons and future strategies
por: Guo, Zong-Sheng
Publicado: (2020) -
Oncolytic Virus Immunotherapy
por: Marchini, Antonio, et al.
Publicado: (2021)